Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Long-Term Investments (2022)

LENZ Therapeutics (LENZ) has disclosed Long-Term Investments for 1 consecutive years, with $15.3 million as the latest value for Q4 2022.

  • Quarterly Long-Term Investments changed N/A to $15.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Dec 2022, changed N/A year-over-year, with the annual reading at $15.3 million for FY2022, N/A changed from the prior year.
  • Long-Term Investments for Q4 2022 was $15.3 million at LENZ Therapeutics, up from $13.4 million in the prior quarter.
  • The five-year high for Long-Term Investments was $15.3 million in Q4 2022, with the low at $6.0 million in Q2 2022.